FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications | US newsNovember 10, 2026
Tech Hims & Hers tightens 2026 outlook after Q3 missesBy Healthcare Propulsion StaffNovember 10, 20260 Digital health and wellness company Hims & Hers tightened its full-year 2026 revenue outlook after missing Wall Street analysts’ revenue…
Research Lilly and Hims & Hers Expand Access to FDA-Approved Lilly MedicinesBy Healthcare Propulsion StaffNovember 6, 20260 ZEPBOUND INDICATIONS AND SAFETY SUMMARY WITH WARNINGSZepbound® (ZEHP-bownd) is an injectable prescription medicine used with a reduced-calorie diet and increased…
Tech Hims & Hers partners with Eli Lilly to sell Zepbound, FoundayoBy Healthcare Propulsion StaffNovember 6, 20260 Hims & Hers struck a deal with Eli Lilly to offer the drugmaker’s branded obesity treatments through its online health…
Tech Weekly Rundown: News from Doximity, Hims & Hers and GoogleBy Healthcare Propulsion StaffOctober 30, 20260 Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief.…
